In our cohort, overexpression of FGF19 occurred in 9 of 63 (14.3%) HCC models tested, of which only 1 of 9 high FGF19-expressing HCC models (HCC29-1104) had FGF19 gene amplification. Here, FGF19 is linked to hepatocellular carcinoma.